Korean Market
PERI
Prestige Biologics
★★★

Prestige Biologics: Q3 Operating Loss of KRW 39.7bn, Debt Ratio Soars to 149%, Cash Depleted

 
EXCH
Prestige Biologics
★★★

Signed Consignment Production Contract for Tech Transfer Raw Material Drugs, 2.4B KRW

 
EXCH
Prestige Biologics
★★★★

Termination of Sole Sales/Supply Contract (Contract Amount 346M Won, 2221.55% of Sales)

 
EXCH
Prestige Biologics
★★★

Correction of Termination of Single Sales/Supply Contract and Continuous Disclosure Reservation